HC Wainwright & Co. cuts Tyra Biosciences price target to $29
HC Wainwright & Co. maintained a Buy rating on Tyra Biosciences and cut its price target to $29.00 per share from $30.00, according to Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.